Janus Henderson Group PLC Vertex Pharmaceuticals Inc Transaction History

Janus Henderson Group PLC

  • $187 Billion
  • Q3 2024

A detailed history of Janus Henderson Group PLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Janus Henderson Group PLC holds 2,516,831 shares of VRTX stock, worth $1.01 Billion. This represents 0.62% of its overall portfolio holdings.

Number of Shares
2,516,831
Previous 2,416,717 4.14%
Holding current value
$1.01 Billion
Previous $1.13 Billion 3.33%
% of portfolio
0.62%
Previous 0.62%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$460.0 - $505.78 $46.1 Million - $50.6 Million
100,114 Added 4.14%
2,516,831 $1.17 Billion
Q2 2024

Aug 14, 2024
SELL
$392.81 - $485.53 $65.8 Million - $81.4 Million
-167,598 Reduced 6.49%
2,416,717 $1.13 Billion
Q1 2024

May 15, 2024
BUY
$407.69 - $446.08 $99.6 Million - $109 Million
244,336 Added 10.44%
2,584,315 $1.08 Billion
Q4 2023

Feb 14, 2024
BUY
$343.0 - $410.68 $234 Million - $280 Million
681,156 Added 41.06%
2,339,979 $952 Million
Q3 2023

Nov 14, 2023
BUY
$338.18 - $362.46 $75.7 Million - $81.2 Million
223,905 Added 15.6%
1,658,823 $577 Million
Q2 2023

Aug 14, 2023
BUY
$314.42 - $351.91 $21.4 Million - $24 Million
68,206 Added 4.99%
1,434,918 $505 Million
Q1 2023

May 15, 2023
SELL
$283.23 - $323.1 $5.31 Million - $6.06 Million
-18,764 Reduced 1.35%
1,366,712 $431 Million
Q4 2022

Feb 14, 2023
SELL
$285.76 - $321.48 $33.2 Million - $37.3 Million
-116,059 Reduced 7.73%
1,385,476 $400 Million
Q3 2022

Nov 14, 2022
SELL
$273.83 - $305.53 $37.6 Million - $42 Million
-137,417 Reduced 8.38%
1,501,535 $435 Million
Q2 2022

Aug 15, 2022
SELL
$234.96 - $292.55 $39.2 Million - $48.8 Million
-166,647 Reduced 9.23%
1,638,952 $462 Million
Q1 2022

May 16, 2022
SELL
$221.42 - $260.97 $41 Million - $48.3 Million
-185,141 Reduced 9.3%
1,805,599 $471 Million
Q4 2021

Feb 14, 2022
SELL
$177.01 - $223.45 $25.5 Million - $32.2 Million
-144,038 Reduced 6.75%
1,990,740 $437 Million
Q3 2021

Nov 16, 2021
SELL
$181.39 - $202.99 $391 Million - $437 Million
-2,153,680 Reduced 50.22%
2,134,778 $387 Million
Q2 2021

Aug 16, 2021
SELL
$187.49 - $221.1 $41.3 Million - $48.7 Million
-220,351 Reduced 4.89%
4,288,458 $865 Million
Q1 2021

May 17, 2021
BUY
$207.02 - $241.31 $70.9 Million - $82.6 Million
342,275 Added 8.21%
4,508,809 $969 Million
Q4 2020

Feb 16, 2021
BUY
$207.01 - $276.09 $469 Million - $626 Million
2,265,577 Added 119.18%
4,166,534 $985 Million
Q3 2020

Nov 16, 2020
SELL
$255.65 - $303.1 $15.9 Million - $18.9 Million
-62,356 Reduced 3.18%
1,900,957 $517 Million
Q2 2020

Aug 14, 2020
BUY
$225.48 - $295.8 $20.7 Million - $27.1 Million
91,678 Added 4.9%
1,963,313 $570 Million
Q1 2020

May 14, 2020
SELL
$199.77 - $247.81 $52.6 Million - $65.2 Million
-263,221 Reduced 12.33%
1,871,635 $445 Million
Q4 2019

Feb 18, 2020
BUY
$166.71 - $223.91 $43.8 Million - $58.8 Million
262,589 Added 14.03%
2,134,856 $467 Million
Q3 2019

Nov 14, 2019
BUY
$166.23 - $187.09 $137 Million - $154 Million
822,331 Added 78.32%
1,872,267 $317 Million
Q2 2019

Jul 31, 2019
BUY
$164.61 - $190.37 $46.7 Million - $54 Million
283,447 Added 36.98%
1,049,936 $193 Million
Q1 2019

Apr 30, 2019
SELL
$163.73 - $194.7 $18.7 Million - $22.2 Million
-114,085 Reduced 12.96%
766,489 $141 Million
Q4 2018

Feb 06, 2019
BUY
$151.91 - $192.21 $55.6 Million - $70.4 Million
366,207 Added 71.2%
880,574 $146 Million
Q3 2018

Nov 09, 2018
SELL
$167.73 - $192.74 $50.4 Million - $57.9 Million
-300,420 Reduced 36.87%
514,367 $99.1 Million
Q2 2018

Aug 10, 2018
SELL
$145.72 - $169.96 $5.46 Million - $6.37 Million
-37,454 Reduced 4.39%
814,787 $138 Million
Q1 2018

May 14, 2018
SELL
$151.6 - $177.13 $48.4 Million - $56.5 Million
-319,130 Reduced 27.24%
852,241 $139 Million
Q4 2017

Feb 09, 2018
BUY
$137.28 - $155.55 $79.6 Million - $90.1 Million
579,501 Added 97.91%
1,171,371 $176 Million
Q3 2017

Nov 14, 2017
BUY
$148.13 - $162.24 $21.2 Million - $23.2 Million
142,895 Added 31.83%
591,870 $0
Q2 2017

Aug 17, 2017
BUY
N/A
448,975
448,975 $57.9 Million

Others Institutions Holding VRTX

# of Institutions
1,725
Shares Held
221M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $103B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email